Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Preity Sharma"'
Autor:
Sanjeev Kumar Gupta, Minu Singh, Pragna H. Chandrashekar, Sameer Bakhshi, Amita Trehan, Ritu Gupta, Rozy Thakur, Smeeta Gajendra, Preity Sharma, Sreejesh Sreedharanunni, Manupdesh S. Sachdeva, Deepam Pushpam, Neelam Varma, Deepak Bansal, Richa Jain, Srinivasan Peyam, Anthony V. Moorman, Prateek Bhatia
Publikováno v:
HemaSphere, Vol 6, Iss 10, p e782 (2022)
Copy number alteration (CNA) status and CNA risk profiles of IKZF1plus, UK-ALL CNA risk groups and MRplus scores, were evaluated for clinical and prognostic impact in a cohort of 493 B-cell acute lymphoblastic leukemia cases diagnosed and treated und
Externí odkaz:
https://doaj.org/article/b950bc5a01cc428cb83e1fab0526250c
Autor:
Preity Sharma, Ranjit Kumar Sahoo, Vineet Kumar Kamal, Deepam Pushpam, Sanjeev Gupta, Ritu Gupta, Sameer Bakhshi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e666-e673
Background IKZF1 deletions are associated with adverse outcomes in B-cell acute lymphoblastic leukemia (B-ALL). We assessed the prevalence and clinical impact of functional subtypes of IKZF1 deletions in pediatric BCR–ABL1-negative B-ALL. Patients
Autor:
Preity Sharma, Sanjeev Kumar Gupta, Gadha K. Leons, Sameer Bakhshi, Ritu Gupta, Lata Rani, Smeeta Gajendra, Anita Roy, Deepam Pushpam
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Sanjeev Gupta, Minu Singh, Pragna HC, Sameer Bakhshi, Amita Trehan, Ritu Gupta, Rozy Thakur, Smeeta Gajendra, Preity Sharma, Sreejesh Sreedharanu, Man Updesh Singh Sachdeva, Deepam Pushpam, Neelam Varma, Deepak Bansal, Richa Jain, srinivasan peyam, Anthony Moorman, Prateek Bhatia
In current study, copy number alteration (CNA) status and CNA risk profiles of IKZF1plus, UK-ALL CNA risk groups and MRplus score, were evaluated for clinical and prognostic impact in a cohort of 493 B-ALL cases diagnosed and treated under ICICLE tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fde86877d59683c284c6139720a5f5c
https://doi.org/10.21203/rs.3.rs-1663909/v1
https://doi.org/10.21203/rs.3.rs-1663909/v1
Autor:
Atul Sharma, Raja Pramanik, Baibaswata Nayak, Shalabh Arora, Ahitagni Biswas, Sampa Ghose, Preity Sharma, Alok Thakar
Publikováno v:
Journal of medical virologyREFERENCES. 94(2)
Nasopharyngeal carcinoma (NPC) is the most common malignant tumor of the nasopharynx. Although NPC is not endemic in India but higher incidences were observed in its North-Eastern regions particularly Sikkim, Nagaland, Manipur, and Mizoram. Early det
Autor:
Ritu Gupta, Sameer Bakhshi, Ranjit Kumar Sahoo, Preity Sharma, Deepam Pushpam, Atul Sharma, Sanjeev Gupta, Vineet Kumar Kamal
Publikováno v:
Leukemia Research. 111:106683
We propose "MRplus", a molecular genetic risk score and check its clinical application in the risk-stratification of pediatric B-ALL.The genomic DNA of untreated pediatricBCR-ABL1 negative B-ALL patients was analyzed for deletions of IKZF1, PAX5, CDK
Autor:
Ritu Gupta, Deepam Pushpam, Sameer Bakhshi, Ranjit Kumar Sahoo, Atul Sharma, Sanjeev Gupta, Preity Sharma
Publikováno v:
Journal of Clinical Oncology. 39:7029-7029
7029 Background: Currently, the molecular risk scoring is variably used in the management algorithms of B-ALL across various clinical cohorts. Unlike AML, the usage of molecular genetic abnormalities in the risk-stratification of B-ALL is limited and
Publikováno v:
Indian Journal of Entomology. 80:239
Publikováno v:
Journal of Clinical Oncology. 25:7043-7043
7043 Background: We prospectively studied BCR-ABL transcript type (b2a2, b3a2, e1a2 and e19a2 in 100 CML-CP patients treated with Imatinib mesylate therapy and studied their correlation with the cytogenetics responses. Methods: Between Aug, 2004 and